Table A2.
Speaker group | # of coefficients | 12 | 14 | 16 | 18 | 20 | Z | p |
---|---|---|---|---|---|---|---|---|
Typically developing |
||||||||
Male adults | F4 | + | −3.771 | .000* | ||||
F3 | + | −4.967 | .000* | |||||
F2 | + | −5.282 | .000* | |||||
F1 | + | −4.852 | .000* | |||||
F4–F1 |
+ |
−9.433 |
.000* |
|||||
Female adults | F4 | + | −1.999 | .046 | ||||
F3 | + | −2.470 | .014 | |||||
F2 | + | −1.331 | .183 | |||||
F1 | + | −0.887 | .375 | |||||
F4–F1 |
+ |
−3.206 |
.001* |
|||||
Male children | F4 | + | −0.621 | .535 | ||||
F3 | + | −0.893 | .372 | |||||
F2 | + | −0.299 | .765 | |||||
F1 | + | −0.187 | .852 | |||||
F4–F1 |
+ |
−0.585 |
.559 |
|||||
Female children | F4 | + | −0.534 | .594 | ||||
F3 | + | −0.187 | .852 | |||||
F2 | + | |||||||
F1 | + | |||||||
F4–F1 |
+ |
|||||||
Down syndrome |
||||||||
Male adults | F4 | + | −2.310 | .021 | ||||
F3 | + | −3.360 | .001* | |||||
F2 | + | −2.651 | .008* | |||||
F1 | + | −1.344 | .179 | |||||
F4–F1 |
+ |
−5.079 |
.000* |
|||||
Female adults | F4 | + | −2.824 | .005* | ||||
F3 | + | −3.375 | .001* | |||||
F2 | + | −2.464 | .014 | |||||
F1 | + | −0.597 | .550 | |||||
F4–F1 |
+ |
−4.948 |
.000* |
|||||
Male children | F4 | + | −0.893 | .372 | ||||
F3 | + | −2.427 | .015 | |||||
F2 | + | −1.083 | .279 | |||||
F1 | + | |||||||
F4–F1 |
+ |
−1.295 |
.195 |
|||||
Female children | F4 | + | −0.260 | .795 | ||||
F3 | + | −0.597 | .550 | |||||
F2 | + | −1.568 | .117 | |||||
F1 | + | |||||||
F4–F1 | + | −0.708 | .479 |
Note. Statistical significance between default and optimal analysis parameter, assessed using the Wilcoxon signed-ranks test, is denoted by an asterisk (*).